© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Latest Conference Articles
Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.
AAO recap: Scientific findings and interviews from New Orleans
November 23rd 2021
A brief overview of the plethora of findings presented at the 2021 American Academy of Ophthalmology meeting held November 12-15 in New Orleans, LA.
Study: PDS offers efficient drug delivery to retina for wet AMD
November 16th 2021
Mark Wieland, MD, explores how Port Delivery System with ranibizumab provides drug delivery over an extended period.
Faricimab provides sustained retinal stability in DME
November 15th 2021
Veeral Sheth, MD, presents research finding faricimab, a bispecific monoclonal antibody, provided sustained retinal stability in patients with diabetic macular edema (DME) compared with other retinal treatments.
AMD progression associated with plasma metabolomic profiles
November 15th 2021
Ines Lains, MD, PhD, explores how mechanisms of AMD progression currently remain poorly understood and the tools to predict and halt progression are limited.
Influence of universal face masks on endophthalmitis risk post-anti-VEGF injections
November 14th 2021
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
FDA-approved eye drops target presbyopia patients
November 14th 2021
Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence.
.png?w=350&fit=crop&auto=format)
ImprimisRx offers a look at three new products in the pipeline
November 14th 2021
ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.
Rare ocular surface tumors often prove deadly
November 14th 2021
Nathan Hall, BS, MS, presents research on how epidemiologic analysis of malignant ocular surface tumors found significant differences in geographic prevalence rates in the United States.
Study examines dosing variability with aflibercept pre-filled syringes
November 14th 2021
Roger A. Goldberg, MD, MBA, notes how small misalignments in the plunger can lead to possible overdosing.
DME: Changes to CST linked to worse visual outcomes
November 13th 2021
Ajay Kuriyan, MD, discusses fluctuations in central subfield thickness associated with worse visual outcomes in patients with diabetic macular edema in clinical trial setting.